Drug Development News

Recent Posts
  • BridgeBio bounces back? Phase 2 readout provides hope for approval of drug to rebalance calcium levels
  • Bluebird Bio gene therapy wins first FDA approval for rare blood disorder
  • Rare Disease Highlight: Stargardt Disease
  • Attralus Receives U.S. FDA Orphan Drug Designation for AT-01 (Iodine (I-124) Evuzamitide), an Investigational Diagnostic for the Management of Transthyretin Amyloidosis
  • ALX Oncology’s Evorpacept Receives Fast Track Designation from FDA as First-Line Treatment for Head and Neck Squamous Cell Carcinoma